These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 25522911)
1. Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling. Cui H; Yuan J; Du X; Wang M; Yue L; Liu J Oncol Rep; 2015 Mar; 33(3):1284-90. PubMed ID: 25522911 [TBL] [Abstract][Full Text] [Related]
2. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390 [TBL] [Abstract][Full Text] [Related]
3. [Effect of ethyl gallate on invasion abilities and its mechanism of breast cancer MDA-MB-231 cells]. Cui HX; Wang M; Yuan JX; Liu JC Yao Xue Xue Bao; 2015 Jan; 50(1):45-9. PubMed ID: 25924474 [TBL] [Abstract][Full Text] [Related]
4. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways. Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819 [TBL] [Abstract][Full Text] [Related]
5. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway. Fan L; Zhang Y; Zhou Q; Liu Y; Gong B; Lü J; Zhu H; Zhu G; Xu Y; Huang G Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30401729 [TBL] [Abstract][Full Text] [Related]
6. Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells. Chung TW; Choi H; Lee JM; Ha SH; Kwak CH; Abekura F; Park JY; Chang YC; Ha KT; Cho SH; Chang HW; Lee YC; Kim CH J Ethnopharmacol; 2017 Jan; 195():309-317. PubMed ID: 27876502 [TBL] [Abstract][Full Text] [Related]
7. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Adams LS; Phung S; Yee N; Seeram NP; Li L; Chen S Cancer Res; 2010 May; 70(9):3594-605. PubMed ID: 20388778 [TBL] [Abstract][Full Text] [Related]
8. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion. Farabegoli F; Govoni M; Spisni E; Papi A Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354 [TBL] [Abstract][Full Text] [Related]
9. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways. Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675 [TBL] [Abstract][Full Text] [Related]
10. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS. Huang L; Lin H; Chen Q; Yu L; Bai D BMC Cancer; 2019 Nov; 19(1):1159. PubMed ID: 31783821 [TBL] [Abstract][Full Text] [Related]
11. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Zhang G; Wang Y; Zhang Y; Wan X; Li J; Liu K; Wang F; Liu K; Liu Q; Yang C; Yu P; Huang Y; Wang S; Jiang P; Qu Z; Luan J; Duan H; Zhang L; Hou A; Jin S; Hsieh TC; Wu E Curr Mol Med; 2012 Feb; 12(2):163-76. PubMed ID: 22280355 [TBL] [Abstract][Full Text] [Related]
12. [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism]. Wang M; Cui HX; Sun C; Li G; Wang HL; Xia CH; Wang YC; Liu JC Yao Xue Xue Bao; 2016 Apr; 51(4):558-62. PubMed ID: 29859524 [TBL] [Abstract][Full Text] [Related]
13. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells. Rabi T; Huwiler A; Zangemeister-Wittke U Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563 [TBL] [Abstract][Full Text] [Related]
14. Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-κB signaling pathway. Wang J; Cui L; Feng L; Zhang Z; Song J; Liu D; Jia X Oncol Rep; 2016 Sep; 36(3):1269-76. PubMed ID: 27461575 [TBL] [Abstract][Full Text] [Related]
15. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Zhou R; Xu L; Ye M; Liao M; Du H; Chen H Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660 [TBL] [Abstract][Full Text] [Related]
16. Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway. Wang Y; Shen SY; Liu L; Zhang XD; Liu DY; Liu N; Liu BH; Shen L J Ethnopharmacol; 2022 Jan; 282():114581. PubMed ID: 34464697 [TBL] [Abstract][Full Text] [Related]
17. Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways. Liao CL; Lai KC; Huang AC; Yang JS; Lin JJ; Wu SH; Gibson Wood W; Lin JG; Chung JG Food Chem Toxicol; 2012 May; 50(5):1734-40. PubMed ID: 22387266 [TBL] [Abstract][Full Text] [Related]
18. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer. Zhao Y; Wang H; Li X; Cao M; Lu H; Meng Q; Pang H; Li H; Nadolny C; Dong X; Cai L J Cell Physiol; 2014 Nov; 229(11):1855-62. PubMed ID: 24692224 [TBL] [Abstract][Full Text] [Related]
19. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016 [TBL] [Abstract][Full Text] [Related]
20. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells. Park SY; Kim YH; Kim Y; Lee SJ Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]